Kuehne + Nagel subsidiary QuickSTAT has opened a new pharma and healthcare control tower and conditioning facility in Singapore. The investment comes as part of Kuehne + Nagel (K+N) and QuickSTAT’s pharma and healthcare strategy to further expand their logistics capabilities to serve customers across Asia Pacific. Singapore is a strategic location for the new QuickSTAT facility due to both its geographical position in the centre of Asia and its status as a leading biomedical hub in the continent.
QuickSTAT manages global clinical trial logistics for all phases of the product lifecycle from research and drug development through to commercialisation. The company specialises in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies and vaccines in order to help bring new drugs and medical protocols to market safely and quickly.
The new facility is located at K+N’s Singapore Logistics Hub and caters to a full suite of healthcare logistics services for all stages of the pharmaceutical product lifecycle. It provides management of cell and gene therapies, with specialists to ensure proper handling, packaging and storage of the time-and-temperature sensitive products. Additionally, the facility includes a controlled-ambient warehouse and in-transit storage for vaccines, investigational drugs, patient clinical specimens and active pharmaceutical ingredients (API).
Jack Liu, Senior Vice President of Air Logistics at K+N Asia Pacific, said, “Kuehne + Nagel is delighted to partner with QuickSTAT to provide seamless end-to-end solutions, adding value to our pharma and healthcare customers in Asia Pacific. With the ISO-certified and GxP compliant facility that upholds the best practices for storage, conditioning, transportation, routings and logistics – I am confident that we will consistently deliver product integrity and patient safety.”
Source: Kuehne + Nagel
